Skip to main content
. 2020 Mar 27;182(6):583–594. doi: 10.1530/EJE-19-0762

Table 3.

Number of patients from the randomized population (n = 198) who had one or more comorbidities at baseline.

Number of comorbidities at baseline Proportion of randomized population, n (%)
1 42 (21.2)
2 41 (20.7)
3 51 (25.8)
4 34 (17.2)
5 13 (6.6)